Global Cell Line & Membrane Market to 2023: Surging Demand for Antibody Production Spurs Growth –

Benzinga - Stock Market News

The “Cell
Line and Membrane Market”
report has been added to‘s

The scope of this report is broad and covers various types of products
available in the cell line and membrane market and potential application
sectors across various industries. The cell line and membrane market is
segmented by cell line product type and membrane type. Revenue forecasts
from 2018 to 2023 are given for each product, application and end user
with estimated values derived from the total revenue of manufacturers.

The report also includes a discussion of the major players across each
region in the cell line and membrane market. Further, it explains the
major drivers and regional dynamics of the global cell line and membrane
market and current trends within the industry.

The report concludes with a special focus on the vendor landscape and
includes detailed profiles of the major vendors in the cell line and
membrane market.

The report includes:

  • 79 data tables and 60 additional tables
  • Identification of applications of cell lines in drug development,
    diagnostics, and molecular biology
  • Description of advancements in cell lines for cancer-based therapies
  • Details of CAR-T Cell and immune check point inhibitor therapy
  • Comparative study of autologous vs allogenic cells manufacturing
  • Explanation of increasing adoption of cell line technologies in
    cell-based assay and surging demand of antibody production as a
    driving force to the cell line market
  • Detailed profiles of the major vendors in the global cell line and
    membrane market, including ATCC, GE Healthcare, Lonza Group,
    Sartorius, Thermo Fisher Scientific and Wuxi AppTec

Key Topics Covered

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

  • Introduction
  • Market Potential
  • Regulatory Framework
  • United States
  • European Union
  • China
  • India
  • Japan
  • Brazil
  • Investment Analysis
  • Industry Growth Drivers
  • Advancement in Technologies Accelerating the Scale-up of Cell Lines
  • High Investment in Cell Culture Technology
  • Increasing Adoption of Cell Line Technologies in Cell-Based Assays
  • Surging Demand for Antibody Production
  • High Investments by Pharmaceutical and Biotechnology Companies in Drug

Chapter 4 Market Breakdown by Product

  • Type of Cell Line
  • Development of Cell Lines and Cell Culture
  • Immunotherapy Cell Lines
  • Ion Channel Cell Lines
  • GPCR Cell Lines
  • Cell Signaling Pathway Cell Lines
  • Gene Knockout Cell Lines
  • Cancer Cell Lines
  • Others
  • Type of Cell Membrane
  • Natural
  • Synthetic

Chapter 5 Market Breakdown by End User

  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Forensic Science Laboratories
  • Food and Beverage Companies
  • Application of Cell Lines and Cell Cultures
  • The Benefits of Using Plant Cell Lines:
  • Microbes for Food and Beverage Production
  • Cell Lines in Clean Meat
  • Diagnostic Centers
  • Lung Cancer Cell Lines as Tools for Biomedical Discovery and Research
    in Diagnostic Centers
  • Cell Membrane Proteomics Can Potentially Identify Breast Cancer
  • Others

Chapter 6 Market Breakdown by Application

  • Drug Discovery and Development
  • Application of Cell Line and Membrane in Drug Discovery and
    Development Process
  • Surging Utilization of Cell Lines in Cancer Pharmagenomics
  • Clinical Trials
  • Basic Research
  • Benefits of Cell Line in Research
  • Toxicity Screening
  • Biopharmaceutical Production
  • The Use of Human Cell Line for Biopharmaceutical Production
  • The Use of CHO Cells for Biopharmaceutical Production
  • Driver
  • Drug Screening
  • Driver
  • Forensic Testing
  • Cell Line Authentication
  • Tissue Engineering
  • Stem Cell Applications in Tissue Engineering
  • Driver

Chapter 7 Market Breakdown by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • RoAPAC
  • RoW (Rest of the World)
  • Latin America
  • Middle East and Africa

Chapter 8 Cell Line and Membrane Market Industry Structure

  • Procurement of Raw Materials
  • Quality
  • Terms and Conditions
  • Cost Effective Components
  • Manufacturing/Development Process
  • End Users
  • Factors Affecting Cell Line and Membrane Market
  • Innovation within the Industry
  • Various Gene Engineering Approaches
  • Advancements in Cell Lines for Cancer-Based Therapies
  • CAR T-Cell Lines and Immune Checkpoint Inhibitors
  • Autologous vs. Allogenic Cells Manufacturing Process
  • Competitive Analysis

Chapter 9 Company Profiles

  • Abzena
  • ACM Biolabs
  • ATCC
  • BD Biosciences
  • BioIVT
  • Catalent Inc.
  • Cell Biolabs Inc.
  • Corning Inc.
  • Creative Biolabs
  • Etubics Corp.
  • GE Healthcare
  • iXCells Biotechnologies
  • Lonza Group Ltd.
  • MI Bioresearch Inc.
  • Merck Millipore
  • Miltenyi Biotec
  • Novus Biologicals
  • Rockland Immunochemicals Inc.
  • Quidel Corp.
  • Sartorius
  • Selexis S.A.
  • Thermo Fisher Scientific
  • Wuxi Apptec

For more information about this report visit

Leave a Reply